These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Characterization of the inhibitory effect of PEG-lipid conjugates on the intracellular delivery of plasmid and antisense DNA mediated by cationic lipid liposomes. Song LY, Ahkong QF, Rong Q, Wang Z, Ansell S, Hope MJ, Mui B. Biochim Biophys Acta; 2002 Jan 02; 1558(1):1-13. PubMed ID: 11750259 [Abstract] [Full Text] [Related]
15. Structural and fusogenic properties of cationic liposomes in the presence of plasmid DNA. Mok KW, Cullis PR. Biophys J; 1997 Nov 02; 73(5):2534-45. PubMed ID: 9370447 [Abstract] [Full Text] [Related]
16. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Hadinoto K, Sundaresan A, Cheow WS. Eur J Pharm Biopharm; 2013 Nov 02; 85(3 Pt A):427-43. PubMed ID: 23872180 [Abstract] [Full Text] [Related]
17. Distal cationic poly(ethylene glycol) lipid conjugates in large unilamellar vesicles prepared by extrusion enhance liposomal cellular uptake. Chen T, Palmer LR, Fenske DB, Lam AM, Wong KF, Cullis PR. J Liposome Res; 2004 Nov 02; 14(3-4):155-73. PubMed ID: 15676124 [Abstract] [Full Text] [Related]
19. Low-pH-sensitive PEG-stabilized plasmid-lipid nanoparticles: preparation and characterization. Choi JS, MacKay JA, Szoka FC. Bioconjug Chem; 2003 Nov 02; 14(2):420-9. PubMed ID: 12643753 [Abstract] [Full Text] [Related]
20. In vivo gene delivery to the liver using novel galactosylated cationic liposomes. Kawakami S, Fumoto S, Nishikawa M, Yamashita F, Hashida M. Pharm Res; 2000 Mar 02; 17(3):306-13. PubMed ID: 10801219 [Abstract] [Full Text] [Related] Page: [Next] [New Search]